Amanta Healthcare IPO Dates, GMP, Financials & Allotment Details
Amanta Healthcare Limited is all set to launch its Mainboard IPO. As a pharmaceutical company with a strong focus on sterile liquid products, Amanta Healthcare is an interesting IPO coming on 1st September for investors. Here's a comprehensive look at what you need to know.
Amanta Healthcare: A Detailed Overview
Amanta Healthcare is a prominent pharmaceutical company specializing in the manufacturing of sterile liquid products, including Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs). Their state-of-the-art production leverages advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies.
The company operates a WHO-GMP certified, 66,852 sq. meter facility in Hariyala, District Kheda, Gujarat, equipped with four LVP and three SVP manufacturing lines. Amanta Healthcare boasts a diverse portfolio of over 45 generic products spanning six therapeutic segments such as fluid therapy, ophthalmics, respiratory care, and irrigation solutions. They offer flexible container fill volumes from 2ml to 1000ml with various closure systems.
With a robust team of 1,727 personnel, including 509 full-time staff and a dedicated Formulation & Development (F&D) and quality control lab with 128 professionals, Amanta Healthcare maintains high standards. Their international footprint extends to 19 countries with 47 products registered across 112 jurisdictions, complemented by a strong domestic distribution network of over 316 stockists and an 108-member sales team. The company also engages in commercial-scale manufacturing and license agreements with Indian and global pharmaceutical firms.
Amanta Healthcare IPO: Key Details
| Particulars | Details |
|---|---|
| IPO Open Date | September 1, 2025 |
| IPO Close Date | September 3, 2025 |
| Price Band | ā¹ Coming soon |
| Lot Size | Coming Soon |
| Issue Size | 1,00,00,000 Shares (Fresh Issue) |
| Face Value | ā¹10 per share |
| Retail Allocation | 35% |
| Lead Manager | Beeline Capital Advisors Private Limited |
| Registrar | MUFG Intime India Private Limited |
| Listing On | NSE, BSE |
Financial Performance Snapshot (INR Crores)
Amanta Healthcare has shown a turnaround from a net loss to profitability in recent fiscal years:
| Particulars | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 262 | 281.6 | 276.1 |
| Net Income (PAT) | (2.1) | 3.6 | 10.5 |
| Margin (%) | (0.81) | 1.29 | 3.82 |
Valuations & Margins
| KPI | FY23 | FY24 | FY25 (Pre-Issue) |
|---|---|---|---|
| EPS | (0.79) | 1.35 | 3.71 |
| RONW (%) | (3.36) | 5.48 | 10.89 |
| NAV | 23.44 | 24.71 | 33.43 |
| ROCE (%) | 12.19 | 12.76 | 13.72 |
| EBITDA (%) | 21.43 | 20.86 | 22.11 |
| Debt/Equity | 3.43 | 3.10 | 2.02 |
Latest Grey Market Premium (GMP)
The Grey Market Premium (GMP) for Amanta Healthcare IPO is currently not yet available. Join our telegram for the latest updates
IPO Objectives
The company intends to utilize the Net Proceeds from the Fresh Issue for the following key objectives:
- Funding Capital Expenditure: Towards civil construction work and the purchase of equipment, plant, and machinery for setting up a new SteriPort manufacturing line at Hariyala, Kheda, Gujarat ā INR 70 crore.
- Funding Capital Expenditure: Towards civil construction work, purchase of equipment, plant, and machinery for setting up a new SVP manufacturing line at Hariyala, Kheda, Gujarat ā INR 30.13 crore.
- General Corporate Purposes: To support various other corporate needs and strategic initiatives.
Promoters of Amanta Healthcare
The promoters of Amanta Healthcare Limited are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendrakumar Patel, and Milcent Appliances Private Limited.
Comparison With Listed Peers
Here's how Amanta Healthcare compares to one of its listed peers in the industry:
| Company | PE Ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
|---|---|---|---|---|---|
| Amanta Healthcare | -- | 3.71 | 10.89 | 33.43 | 276.09 |
| Denis Chem Lab | 15.92 | 5.82 | 9.49 | 61.33 | 175.67 |
Important Dates
| Event | Date |
|---|---|
| IPO Opening Date | September 1, 2025 |
| IPO Closing Date | September 3, 2025 |
| Finalization of Basis of Allotment | September 4, 2025 |
| Initiation of Refunds | September 5, 2025 |
| Transfer of Shares to Demat Accounts | September 5, 2025 |
| Amanta Healthcare IPO Listing Date | September 8, 2025 |
Frequently Asked Questions (FAQs)
1. What is Amanta Healthcare Limited?
Amanta Healthcare Limited is a pharmaceutical company specializing in sterile liquid products, including Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), utilizing advanced manufacturing technologies.
2. What are the Amanta Healthcare IPO dates?
The IPO opens on September 1, 2025, and closes on September 3, 2025.
3. What is the price band and lot size for the IPO?
The price band and the lot size is coming soon.
4. What is the Grey Market Premium (GMP) for Amanta Healthcare IPO?
The GMP for Amanta Healthcare IPO is not yet available. Investors should refer to official sources closer to the IPO date.
5. How many shares in Amanta Healthcare IPO are reserved for HNIs and retail investors?
The IPO has a retail allocation of 35%. The remaining is divided between Qualified Institutional Buyers (QIBs) at 50% and Non-Institutional Investors (NIIs) at 15%.
6. What are the main objectives of the Amanta Healthcare IPO?
The primary objectives are to fund capital expenditure for new SteriPort and SVP manufacturing lines at Hariyala, Kheda, Gujarat, and for general corporate purposes.
7. How to apply for the Amanta Healthcare Public Offer?
You can apply for the Amanta Healthcare public offer through Internet banking ASBA (Application Supported by Blocked Amount) or online through your stockbroker using UPI. Offline IPO forms can also be submitted to your broker.
8. When will the Amanta Healthcare IPO shares be listed?
The shares are tentatively scheduled to be listed on September 8, 2025, on both NSE and BSE.